Notochordal cell-based treatment strategies and their potential in intervertebral disc regeneration

BACH, Frances C., PORAMBA-LIYANAGE, Deepani W., RIEMERS, Frank M., GUICHEUX, Jerome, CAMUS, Anne, IATRIDIS, James C., CHAN, Danny, ITO, Keita, LE MAITRE, Christine and TRYFONIDOU, Marianna A. (2022). Notochordal cell-based treatment strategies and their potential in intervertebral disc regeneration. Frontiers in Cell and Developmental Biology, 9.

[img]
Preview
PDF
fcell-09-780749.pdf - Published Version
Creative Commons Attribution.

Download (4MB) | Preview
[img]
Preview
PDF (Table 1)
Le Maitre-NotochordalCell-based(Supp1).pdf - Supplemental Material
Creative Commons Attribution.

Download (114kB) | Preview
[img]
Preview
PDF (Table 2)
Le Maitre-NotochordalCell-based(Supp2).pdf - Supplemental Material
Creative Commons Attribution.

Download (99kB) | Preview
Official URL: https://www.frontiersin.org/articles/10.3389/fcell...
Open Access URL: https://www.frontiersin.org/articles/10.3389/fcell... (Published version)
Link to published version:: https://doi.org/10.3389/fcell.2021.780749
Related URLs:

    Abstract

    Chronic low back pain is the number one cause of years lived with disability. In about 40% of patients, chronic lower back pain is related to intervertebral disc (IVD) degeneration. The standard-of-care focuses on symptomatic relief, while surgery is the last resort. Emerging therapeutic strategies target the underlying cause of IVD degeneration and increasingly focus on the relatively overlooked notochordal cells (NCs). NCs are derived from the notochord and once the notochord regresses they remain in the core of the developing IVD, the nucleus pulposus. The large vacuolated NCs rapidly decline after birth and are replaced by the smaller nucleus pulposus cells with maturation, ageing, and degeneration. Here, we provide an update on the journey of NCs and discuss the cell markers and tools that can be used to study their fate and regenerative capacity. We review the therapeutic potential of NCs for the treatment of IVD-related lower back pain and outline important future directions in this area. Promising studies indicate that NCs and their secretome exerts regenerative effects, via increased proliferation, extracellular matrix production, and anti-inflammatory effects. Reports on NC-like cells derived from embryonic- or induced pluripotent-stem cells claim to have successfully generated NC-like cells but did not compare them with native NCs for phenotypic markers or in terms of their regenerative capacity. Altogether, this is an emerging and active field of research with exciting possibilities. NC-based studies demonstrate that cues from developmental biology can pave the path for future clinical therapies focused on regenerating the diseased IVD.

    Item Type: Article
    Additional Information: ** From Frontiers via Jisc Publications Router ** Licence for this article: http://creativecommons.org/licenses/by/4.0/ **Journal IDs: eissn 2296-634X **Article IDs: publisher-id: 780749 **History: published_online 14-03-2022; accepted 15-11-2021; submitted 21-09-2021; collection 2021
    Uncontrolled Keywords: Cell and Developmental Biology, intervertebral disc – degeneration, conditioned media (CM), secretome, low back pain, extracellular matrix (ECM), cell therapeutic potential, Notochordal cell
    Identification Number: https://doi.org/10.3389/fcell.2021.780749
    SWORD Depositor: Colin Knott
    Depositing User: Colin Knott
    Date Deposited: 30 Mar 2022 10:17
    Last Modified: 30 Mar 2022 10:30
    URI: https://shura.shu.ac.uk/id/eprint/30009

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics